Target Ovarian Cancer PSA Video
Links shared publicly online about this topic.
- 1,055total visits
Target Ovarian Cancer PSA Video
View full resource at vodpod.com
Tags: Cancer, Ovarian Cancer, Disease and Condition, Women's Health, disease
Most Recently Shared on June 30, 2010 at 11:09 pm By:
Target Ovarian Cancer is a charity that helps to raise awareness of this all too common disease AND to give help and s… http://bit.ly/b0ZaK1
Scientists Image Beginning Stages of Ovarian Cancer Growth with Time Lapse Technique
newswise.com — “1) New model of time-lapse microscopy provides better visualization of metastatic processes; 2) Knowledge could allow for therapeutic targeting to prevent metastasis. 3) NOTE TO PRODUCERS/EDITORS: Video footage available.” View full resource at newswise.com
Most Recently Shared on June 14, 2011 at 6:08 pm By:
#health news: Scientists Image Beginning Stages of Ovarian Cancer Growth with Time Lapse Technique: 1) New model... http://bit.ly/kAaTBB
Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter rand” View full resource at medpagetoday.com
Most Recently Shared on June 8, 2011 at 10:08 pm By:
ASCO: Targeted Agent Slows Recurrent Ovarian Cancer (with video) http://bit.ly/m03Klj
Medical News: Bevacizumab Value in Ovarian Cancer Questioned - in Clinical Context, Ovarian Cancer from MedPage Today
medpagetoday.com — “The controversial targeted agent bevacizumab (Avastin) is not cost-effective for patients with advanced ovarian cancer, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on March 8, 2011 at 10:02 pm By:
Bevacizumab Value in Ovarian Cancer Questioned (CME/CE, with video) http://bit.ly/g4wKpl
Bevacizumab Value in Ovarian Cancer Questioned (CME/CE, with video) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The controversial targeted agent bevacizumab (Avastin) is not cost-effective for patients with advanced ovarian cancer, researchers reported.” View full resource at qualitypointtech.net
Most Recently Shared on March 8, 2011 at 10:00 pm By:
Bevacizumab Value in Ovarian Cancer Questioned (CME/CE, with video): (MedPage Today) -- The controversial targeted... http://bit.ly/f5UiXJ
Dream Team targets molecular factors common in women's cancers - icyou health videos
icyou.com — “First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. ...” View full resource at icyou.com
Most Recently Shared on September 17, 2010 at 6:23 pm By:
Tori Joseph - icyou.com Health Site
Dream Team targets molecular factors common in women's cancers http://bit.ly/bjctEb @MDAndersonNews
Ovarian cancer research (ASCO 2010) Video
vodpod.com — “Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is research targeting the VEGF protein. A key presentation at ASCO 2010 has shown that a maintenance treatment of avastin, a targeted therapy that blocks VEGF, increases overall survival in ovarian cancer patients. The second area discussed is research into PARP inhibitors. After some spectacular initial results in women with BRCA mutations, a trial presented at ASCO 2010 has shown that ol” View full resource at vodpod.com
Most Recently Shared on July 21, 2010 at 5:00 am By:
Paul Cacciatore Patient Advocate
Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is researc… http://bit.ly/bROVq0
Surviving Ovarian Cancer : Ovarian Cancer Nat'l Alliance PSA Video
vodpod.com — “A Public Service Announcement brought to you by the Ovarian Cancer National Alliance. To learn more go to www.ovariancancer.org 30 Jun 10. A Public Service Announcement brought to you by the Ovarian Cancer National Alliance.” View full resource at vodpod.com
Most Recently Shared on June 30, 2010 at 11:04 pm By:
Paul Cacciatore Patient Advocate
A Public Service Announcement brought to you by the Ovarian Cancer National Alliance. To learn more go to www.ovarianc… http://bit.ly/aavBdf
Cincinnati Roller Girls PSA - Hereditary Breast and Ovarian Cancer Video
vodpod.com — “Learn the signs of hereditary breast and ovarian cancer and see if you are at increased risk. To learn more go to www.facingourrisk.org. 30 Jun 10. Learn the signs of hereditary breast and ovarian cancer and see if you are at increased risk.” View full resource at vodpod.com
Most Recently Shared on June 30, 2010 at 10:40 pm By:
Paul Cacciatore Patient Advocate
Learn the signs of hereditary breast and ovarian cancer and see if you are at increased risk. To learn more go to www.… http://bit.ly/djFYaT
Kim Kardashian & Kelly Ripa's PSA For Ovarian Cancer Research Video
vodpod.com — “Kim Kardashian teams up with Kelly Ripa for QVC's Super Saturday to raise money for the Ovarian Cancer Research Fund. KIM KARDASHIAN AND KELLY RIPA PLAY DRESS UP TO FIGHT OVARIAN CANCER... THE 2 petite HOTTIES TEAMED UP FOR A PSA FOR QVC'S SUPER SATURDAY, WHICH IS A SHOPPING EVENT IN THE HAMPTONS THAT BENEFITS THE OVARIAN CANCER RESEARCH FUND. BEHIND THE SCENES, KELLY and kim WIGGED OUT ,MASKED THEIR GREAT LOOKS AND EVEN SHOWED OFF SOME OF THE GOODS going on sale ON SUPER SATURDAY... JULY 31ST I” View full resource at vodpod.com
Most Recently Shared on June 30, 2010 at 10:31 pm By:
Paul Cacciatore Patient Advocate
Kim Kardashian teams up with Kelly Ripa for QVC's Super Saturday to raise money for the Ovarian Cancer Research Fund. … http://bit.ly/ckl8dd
2010 ASCO: Biologic Agent Reduces Ovarian Cancer Relapse Risk - in Meeting Coverage, ASCO from MedPage Today Video
vodpod.com — “Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and related cancers, a researcher said here. Maintenance therapy with bevacizumab (Avastin) after standard chemotherapy decreased the risk of progression by 28% compared with chemo alone, according to Robert Burger, MD, of Fox Chase Cancer Center in Philadelphia. The approach should now be considered "one standard option" for women with advanced epithelial ovarian, primary” View full resource at vodpod.com
Most Recently Shared on June 6, 2010 at 10:58 pm By:
Paul Cacciatore Patient Advocate
Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and… http://bit.ly/dmsYS9
Advertisement
